Odkaz k nastavení vašeho hesla byl poslán na adresu Do budoucna budete k přístupu ke svým nákupům potřebovat heslo.

**226 výsledků pro sglt2 v kategorii vše**

Zobrazit sglt2 ve videích (52)

SEM Image of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitor Semaglutide with High-Resolution Detail Showcasing Its Complex Structure.

Sodium-glucose cotransporter 2 (SGLT2) in complex with a inhibitor, which reduces blood glucose levels

ERTUGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor in plastic box

00:30

D of Insulins Role in Promoting Protein Synthesis and Cell Growth

Empagliflozin pill with the name printed on it, blue background

Canagliflozin A SGLT2 inhibitor used to lower blood sugar

Empagliflozin Capsule

00:08

FORXIGA Pill Box with Stethoscope

Ertugliflozin molecule, rotating 3D model of steglatro, looped video on a black background

00:15

Bexagliflozin diabetes drug molecule.

Bexagliflozin, drug/SGLT2 inhibitor for type 2 diabetes, 3D molecule 4K

SGLT2 Inhibitor Cardiorenal Protection Mechanism Heart Failure

Nephron ion transporters overview highlights key channels Naand-Kand ATPase, NKCC2, and ENaC across tubular epithelium, showing sodium, chloride, and potassium flow. Outline diagram

Diabetes type 2 treatment, antidiabetic drugs. Adult-onset diabetes. Diabetes mellitus type 2, cells fail to respond to insulin (Insulin resistance). Vector illustration.

Canagliflozin molecule. It is antidiabetic medication, SGLT2 inhibitor. Molecular model. 3D rendering

Empagliflozin Medication for Type 2 Diabetes Treatment, SGLT2 Inhibitor Therapy, Blood Glucose Control, Cardiovascular Risk Reduction, Modern Antidiabetic Drug Concept in Healthcare and Pharmacology

A transparent bottle containing medical pills for the SGLT2 inhibitor stands out against a blue background

Bologna - Italy - April 3, 2026: A box of Forxiga 10 mg tablets containing dapagliflozin manufactured by Astrazeneca for treating diabetes and heart failure.

Proximal Convoluted Tubule Lumen: Glucose and Sodium Reabsorption via Brush Border Microvilli (SGLT2 Mechanism Concept) - 3D Rendering

Ertugliflozin diabetes drug molecule. Skeletal formula.

Empagliflozin molecular structure, flat skeletal chemical formula. SGLT2 inhibitor drug used to treat Diabetes type 2. Vector illustration.

Empagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.

IPRAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor in plastic box

00:30

Prague,Czech republic-June6 2023: FORXIGA (dapagliflozin), diabetes medication from gliflozin group, sglt2 inhibitor.

TOFOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor in plastic box

00:30

TOFOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor in plastic box

00:30

Prague,Czech republic-June6 2023: FORXIGA (dapagliflozin), diabetes medication from gliflozin group, sglt2 inhibitor.

SGLT 1/2 inhibitor medication affecting glucose transport for diabetes treatment

00:15

Bexagliflozin diabetes drug molecule.

BEXAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor in plastic box

00:30

EMPAGLIFLOZIN tablets used to treat type 2 diabetes and reduce cardiovascular risk an SGLT2 inhibitor

00:15

SGLT 1/2 inhibitor medication affecting glucose transport for diabetes treatment

00:15

Looped video of Ertugliflozin, steglatro, rotating molecular 3D ball-and-stick model

00:15

Empagliflozin tablets used to treat type 2 diabetes and lower cardiovascular risk, SGLT2 inhibitor class

SGLT 1/2 dual inhibitors used for glucose control in diabetes and metabolic disorders

00:15

Prague,Czech republic-December 12 2024: FORXIGA (dapagliflozin), diabetes medication from gliflozin group, sglt2 inhibitor.

Ertugliflozin rotating molecular structure, 3d model of molecule, steglatro, looped video

00:15

Ertugliflozin, drug/SGLT2 inhibitor for type 2 diabetes and obesity, 3D molecule spinning, 4K

00:16

Prague,Czech republic-June6 2023: FORXIGA (dapagliflozin), diabetes medication from gliflozin group, sglt2 inhibitor.Dapagliflozine active substance

Ertugliflozin (Segluromet, Steglatro, Steglujan) type 2 diabetes mellitus /antidiabetic drug, 3D molecule in 4K

Empagliflozin tablets used to treat type 2 diabetes and lower cardiovascular risk, SGLT2 inhibitor class Empagliflozine

00:30

Bexagliflozin, drug/SGLT2 inhibitor for type 2 diabetes, 3D molecule spinning, 4K

00:16

DAPAGLIFLOZIN tablets used to treat type 2 diabetes,heart failure and chronic kidney disease an SGLT2 inhibitor in plastic box

00:30

FORXIGA Pill Box

Hypertension Sodium-Glucose Transporter Inhibitor Kidney Effect

Heart Failure Cardioprotective Empagliflozin Trial Outcome Chart

Heart Failure With Reduced Ejection Fraction HFrEF Treatment Diagram

Cardiovascular Outcome Trial CVOT Diabetes Drug Safety Study

CANAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes

00:26

IPRAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

SGLT2 INHIBITOR tablets used to lower blood sugar by increasing glucose excretion

00:26

DAPAGLIFLOZIN PROPANEDIOL SGLT2 inhibitor for type 2 diabetes heart failure and kidney disease

00:18

Proximal convoluted tubule reabsorption mapped in an epithelial cell, key elements are Naand-Kand ATPase pump, SGLT2 cotransporter, and aquaporin channels moving water. Outline diagram

DAPAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes heart failure and kidney disease

00:18

ertugliflozin molecular structure, 3d model molecule, steglatro, structural chemical formula view from a microscope

LUSEOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

DAPAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes heart failure and kidney disease

00:30

EMPAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes heart failure and kidney disease

00:30

CANAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes

00:30

CANAGLIFLOZIN METFORMIN SGLT2 inhibitor for type 2 diabetes

00:30

SGLT2 Inhibitor Kidney Glucose Excretion Drug Mechanism Diagram

SGLT2 INHIBITOR class for type 2 diabetes heart failure and kidney protection

EMPAGLIFLOZIN SGLT2 inhibitor for type 2 diabetes heart failure and kidney disease bottle with tablets in pharmacy

ERTUGLIFLOZIN PIDOLATE SGLT2 inhibitor for type 2 diabetes and blood glucose control bottle with tablets in pharmacy

CANAGLIFLOZIN tablets used to treat type 2 diabetes and improve glycemic control an SGLT2 inhibitor in plastic box

00:30

EMPAGLIFLOZIN tablets used to treat type 2 diabetes and reduce cardiovascular risk an SGLT2 inhibitor in plastic box

00:30

Prague,Czech republic-December 12 2024: FORXIGA (dapagliflozin), diabetes medication from gliflozin group, sglt2 inhibitor.

ertugliflozin molecule 3d rendering, flat molecular structure with chemical formula and atoms color coding

Nephron ion transporters overview highlights key channels Naand-Kand ATPase, NKCC2, and ENaC across tubular epithelium, showing sodium, chloride, and potassium flow, transparent background.

LUSEOGLIFLOZIN tablets for treat type 2 diabetes an SGLT2 inhibitor

Ertugliflozin, drug/SGLT2 inhibitor for type 2 diabetes and obesity, 3D molecule 4K

Empagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and heart failure, 3D molecule spinning, 4K

00:16

Empagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and heart failure, 3D molecule 4K

SGLT2 INHIBITOR tablets used to lower blood sugar by increasing glucose excretion

00:15

LUSEOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:15

TOFOGLIFLOZIN tablets for treat type 2 diabetes an SGLT2 inhibitor

00:26

BEXAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:15

Canagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and kidney disease, 3D molecule 4K

SOTAGLIFLOZIN tablets used to treat diabetes by inhibiting SGLT1 and SGLT2 transporters

00:15

Box of CANAGLIFLOZIN tablets on a hospital pharmacy table used to control blood sugar in type 2 diabetes an SGLT2 inhibitor.

TOFOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:15

Canagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and kidney disease, 3D molecule spinning, 4K

00:16

Dapagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and heart failure, 3D molecule 4K

Dapagliflozin, drug/SGLT2 inhibitor for type 2 diabetes and heart failure, 3D molecule spinning, 4K

00:16

ERTUGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:15

Box of DAPAGLIFLOZIN tablets on a hospital pharmacy table used to treat type 2 diabetes heart failure and CKD an SGLT2 inhibitor

TOFOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

Prague,Czech Republic-23.01.2026: Synjardy by Boehringer Ingelheim containing empagliflozin and metformin is used for treatment of type 2 diabetes mellitus

Box of DAPAGLIFLOZIN tablets on a hospital pharmacy table used to treat type 2 diabetes heart failure and CKD an SGLT2 inhibitor

SGLT2 INHIBITOR tablets used to lower blood sugar by increasing glucose excretion

00:15

IPRAGLIFLOZIN tablets for treat type 2 diabetes an SGLT2 inhibitor

SOTAGLIFLOZIN tablets used to treat diabetes by inhibiting SGLT1 and SGLT2 transporters

00:15

CANAGLIFLOZIN tablets used to treat type 2 diabetes and improve glycemic control an SGLT2 inhibitor

00:15

Prague,Czech Republic-23.01.2026: Jardiance by Boehringer Ingelheim containing empagliflozin is an SGLT2 inhibitor used for treatment of type 2 diabetes and cardiovascular risk reduction

ERTUGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

IPRAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

BEXAGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

SGLT 1/2 dual inhibitors used for glucose control in diabetes and metabolic disorders

00:15

SOTAGLIFLOZIN tablets used to treat diabetes by inhibiting SGLT1 and SGLT2 transporters

00:26

LUSEOGLIFLOZIN tablets used to treat type 2 diabetes an SGLT2 inhibitor

00:26

Zkuste také: sglt2 v obrázky, sglt2 v videa, sglt2 v Premium